TGFB1 and kidney disorder: We further showed that a PI polyamide targeting TGF-β1 could effectively retard the progression of renal diseases [11,12], post-angioplasty carotid artery stenosis [13], cornea fibrosis by alkali burns [14], skin hypertrophic scars [15], liver fibrosis [16], and encapsulating peritoneal sclerosis [17] in rats.